ArticlePlants (Basel, Switzerland)2024
Comprehensive Evaluation and Selection of 192 Maize Accessions from Different Sources.
Article in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Article
- Multivariate trait profiling and genetic diversity in a global foxtail millet germplasm panel.Plant biology (Stuttgart, Germany) · 2026Article
- Construction of an Evaluation System and Comprehensive Assessment of the Suitability of Different Processing Peppers for Mechanized Transplanting and Harvesting.Plants (Basel, Switzerland) · 2026Article
- Drought Tolerance Evaluation and Classification of Foxtail Millet Core Germplasms Using Comprehensive Tolerance Indices.Life (Basel, Switzerland) · 2025Article
- Genetic Diversity Analysis of Water Lily Germplasms Based on Morphological Traits and SSR Markers.Plants (Basel, Switzerland) · 2025Article
- Effects of environmental factors on the phenotypic traits and seed element accumulation of wild Elymus nutans in Tibet.Scientific reports · 2025Article
- Diversity analysis, nutrition, and flavor evaluation of amino acids in Chinese native geese germplasms.Veterinary world · 2024Article
- Differences in Physiological and Agronomic Traits and Evaluation of Adaptation of Seven Maize Varieties.Biology · 2024Article
- Comprehensive Evaluation and Selection of Cardamom (Plants (Basel, Switzerland) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In the period 2022-2023, an analysis of fourteen phenotypic traits was conducted across 192 maize accessions in the Aral region of Xinjiang. The Shannon-Wiener diversity index was employed to quantify the phenotypic diversity among the accessions. Subsequently, a comprehensive evaluation of the index was performed utilizing correlation analysis, principal component analysis (PCA) and cluster analysis. The results highlighted significant findings: (1) A pronounced diversity was evident across the 192 maize accessions, accompanied by complex interrelationships among the traits. (2) The 14 phenotypic traits were transformed into 3 independent indicators through principal component analysis: spike factor, leaf width factor, and number of spikes per plant. (3) The 192 materials were divided into three groups using cluster analysis. The phenotypes in Group III exhibited the best performance, followed by those in Group I, and finally Group II. The selection of the three groups can vary depending on the breeding objectives. This study analysed the diversity of phenotypic traits in maize germplasm resources. Maize germplasm was categorised based on similar phenotypes. These findings provide theoretical insights for the study of maize accessions under analogous climatic conditions in Alar City, which lay the groundwork for the efficient utilization of existing germplasm as well as the development and selection of new varieties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.